Refine
Has Fulltext
- yes (46)
Is part of the Bibliography
- yes (46)
Year of publication
Document Type
- Doctoral Thesis (30)
- Journal article (16)
Keywords
- Staphylococcus aureus (46) (remove)
Institute
- Institut für Molekulare Infektionsbiologie (16)
- Graduate School of Life Sciences (13)
- Theodor-Boveri-Institut für Biowissenschaften (12)
- Institut für Hygiene und Mikrobiologie (5)
- Rudolf-Virchow-Zentrum (4)
- Institut für Pharmazie und Lebensmittelchemie (2)
- Fakultät für Biologie (1)
- Frauenklinik und Poliklinik (1)
- Institut für Humangenetik (1)
- Institut für Klinische Biochemie und Pathobiochemie (1)
Sonstige beteiligte Institutionen
Identification of human host cell factors involved in \(Staphylococcus\) \(aureus\) 6850 infection
(2015)
Staphylococcus aureus is both a human commensal and a pathogen. 20%-30% of all individuals are permanently or occasionally carriers of S. aureus without any symptoms. In contrast to this, S. aureus can cause life-threatening diseases e.g. endocarditis, osteomyelitis or sepsis. Here, the increase in antibiotic resistances makes it more and more difficult to treat these infections and hence the number of fatalities rises constantly. Since the pharmaceutical industry has no fundamentally new antibiotics in their pipeline, it is essential to better understand the interplay between S. aureus and the human host cell in order to find new, innovative treatment options.
In this study, a RNA interference based whole genome pool screen was performed to identify human proteins, which play a role during S. aureus infections. Since 1,600 invasion and 2,271 cell death linked factors were enriched at least 2 fold, the big challenge was to filter out the important ones. Here, a STRING pathway analysis proved to be the best option. Subsequently, the identified hits were validated with the help of inhibitors and a second, individualised small interfering RNA-based screen.
In the course of this work two important steps were identified, that are critical for host cell death: the first is bacterial invasion, the second phagosomal escape. The second step is obligatory for intracellular bacterial replication and subsequent host cell death. Invasion in turn is determining for all following events. Accordingly, the effect of the identified factors towards these two crucial steps was determined. Under screening conditions, escape was indirectly measured via intracellular replication. Three inhibitors (JNKII, Methyl-beta-cyclodeytrin, 9-Phenantrol) could be identified for the invasion process. In addition, siRNAs targeted against 16 different genes (including CAPN2, CAPN4 and PIK3CG), could significantly reduce bacterial invasion. Seven siRNAs (FPR2, CAPN4, JUN, LYN, HRAS, AKT1, ITGAM) were able to inhibit intracellular replication significantly. Further studies showed that the IP3 receptor inhibitor 2-APB, the calpain inhibitor calpeptin and the proteasome inhibitor MG-132 are able to prevent phagosomal escape and as a consequence intracellular replication and host cell death.
In this context the role of calpains, calcium, the proteasome and the mitochondrial membrane potential was further investigated in cell culture. Here, an antagonistic behaviour of calpain 1 and 2 during bacterial invasion was observed. Intracellular calcium signalling plays a major role, since its inhibition protects host cells from death. Beside this, the loss of mitochondrial membrane potential is characteristic for S. aureus infection but not responsible for host cell death. The reduction of membrane potential can be significantly diminished by the inhibition of the mitochondrial Na+/Ca2+ exchanger.
All together, this work shows that human host cells massively contribute to different steps in S. aureus infection rather than being simply killed by bacterial pore-forming toxins. Various individual host cell factors were identified, which contribute either to invasion or to phagosomal escape and therefore to S. aureus induced cytotoxicity. Finally, several inhibitors of S. aureus infection were identified. One of them, 2-APB, was already tested in a sepsis mouse model and reduced bacterial load of kidneys.
Thus, this study shows valuable evidence for novel treatment options against S. aureus infections, based on the manipulation of host cell signalling cascades.
The role of multicellularity as the predominant microbial lifestyle has been affirmed by studies on the genetic regulation of biofilms and the conditions driving their formation. Biofilms are of prime importance for the pathology of chronic infections of the opportunistic human pathogen Staphylococcus aureus.
The recent development of a macrocolony biofilm model in S. aureus opened new opportunities to study evolution and physiological specialization in biofilm communities in this organism. In the macrocolony biofilm model, bacteria form complex aggregates with a sophisticated spatial organization on the micro- and macroscale. The central positive and negative regulators of this organization in S. aureus are the alternative sigma factor σB and the quorum sensing system Agr, respectively. Nevertheless, nothing is known on additional factors controlling the macrocolony morphogenesis.
In this work, the genome of S. aureus was screened for novel factors that are required for the development of the macrocolony architecture. A central role for basic metabolic pathways was demonstrated in this context as the macrocolony architecture was strongly altered by the disruption of nucleotide and carbohydrate synthesis. Environmental signals further modulate macrocolony morphogenesis as illustrated by the role of an oxygen-sensitive gene regulator, which is required for the formation of complex surface structures. A further application of the macrocolony biofilm model was demonstrated in the study of interstrain interactions. The integrity of macrocolony communities was macroscopically visibly disturbed by competitive interactions between clinical isolates of S. aureus.
The results of this work contribute to the characterization of the macrocolony biofilm model and improve our understanding of developmental processes relevant in staphylococcal infections. The identification of anti-biofilm effects exercised through competitive interactions could lead to the design of novel antimicrobial strategies targeting multicellular bacterial communities.
Methionine is the first amino acid of every newly synthesised protein. In combination with its role as precursor for the vital methyl-group donor S-adenosylmethionine, methionine is essential for every living cell. The opportunistic human pathogen Staphylococcus aureus is capable of synthesising methionine de novo, when it becomes scarce in the environment. All genes required for the de novo biosynthesis are encoded by the metICFE-mdh operon, except for metX. Expression is controlled by a hierarchical network with a methionyl-tRNA-specific T-box riboswitch (MET-TBRS) as centrepiece, that is also referred to as met leader (RNA). T-box riboswitches (TBRS) are regulatory RNA elements located in the 5’-untranslated region (5’-UTR) of genes. The effector molecule of T-box riboswitches is uncharged cognate tRNA. The prevailing mechanism of action is premature termination of transcription of the nascent RNA in the absence of the effector (i.e. uncharged cognate tRNA) due to formation of a hairpin structure, the Terminator stem. In presence of the effector, a transient stabilisation of the alternative structure, the Antiterminator, enables transcription of the downstream genes (‘read-through’). Albeit, after the read-through the thermodynamically more stable Terminator eventually forms. The Terminator and the Antiterminator are two mutually exclusive structures. Previous work of the research group showed that in staphylococci the MET-TBRS ensures strictly methionine-dependent control of met operon expression. Uncharged methionyl-tRNA that activates the system is only present in sufficient amounts under methionine-deprived conditions. In contrast to other bacterial TBRS, the staphylococcal MET-TBRS has some characteristic features regarding its length and predicted secondary structure whose relevance for the function are yet unkown.
Aim of the present thesis was to experimentally determine the structure of the met leader RNA and to investigate the stability of the met operon-specific transcripts in the context of methionine biosynthesis control. Furthermore, the yet unknown function of the mdh gene within the met operon was to be determined.
In the context of this thesis, the secondary structure of the met leader was determined employing in-line probing. The structural analysis revealed the presence of almost all highly conserved T-box riboswitch structural characteristics. Furthermore, three additional stems, absent in all T-box riboswitches analysed to date, could be identified. Particularly remarkable is the above average length of the Terminator stem which renders it a potential target of the double-strand-specific endoribonuclease III (RNase III). The RNase III-dependent cleavage of the met leader could be experimentally verified by the use of suitable mutants. Moreover, the exact cleavage site within the Terminator was determined.
The unusual immediate separation of the met leader from the met operon mRNA via the RNase III cleavage within the Terminator stem induces the rapid degradation of the met leader RNA and, most likely, that of the 5’-region of the met mRNA. The met mRNA is degraded from its 5’-end by the exoribonuclease RNase J. The stability of the met mRNA was found to vary over the length of the transcript with an instable 5’-end (metI and metC) and a longer half-life towards the 3’-end (metE and mdh). The varying transcript stability is reflected by differences in the available cellular protein levels. The obtained data suggest that programmed mRNA degradation is another level of regulation in the complex network of staphylococcal de novo methionine biosynthesis control.
In addition, the MET-TBRS was studied with regard to a future use as a drug target for novel antimicrobial agents. To this end, effects of a dysregulated methionine biosynthesis on bacterial growth and survival were investigated in met leader mutants that either caused permanent transcription of the met operon (‘ON’) or prevented operon transcription (‘OFF’), irrespective of the methionine status in the cell. Methionine deprivation turned out to be a strong selection pressure, as ‘OFF’ mutants acquired adaptive mutations within the met leader to restore met operon expression that subsequently re-enabled growth.
The second part of the thesis was dedicated to the characterisation of the Mdh protein that is encoded by the last gene of the met operon and whose function is unknown yet. At first, co-transcription and -expression with the met operon could be demonstrated. Next, the Mdh protein was overexpressed and purified and the crystal structure of Mdh was solved to high resolution by the Kisker research group (Rudolf-Virchow-Zentrum Würzburg). Analysis of the structure revealed the amino acid residues crucial for catalytic activity, and zinc was identified as a co-factor of Mdh. Also, Mdh was shown to exist as a dimer. However, identification of the Mdh substrate was, in the context of this thesis, (still) unsuccessful. Nevertheless, interactions of Mdh with enzymes of the met operon could be demonstrated by employing the bacterial two-hybrid system. This fact and the high conservation of mdh/Mdh on nucleotide and amino acid level among numerous staphylococcal species suggests an important role of Mdh within the methionine metabolism that should be a worthwhile subject of future research.
Bislang inhibieren antibakterielle Substanzen in erster Linie die Zellwandsynthese, den DNA- und RNA-Stoffwechsel sowie die Proteinsynthese. In dieser Arbeit wurde ein erster Versuch unternommen, neue Zielstrukturen für die Antibiotika-Therapie in S. aureus zu finden. Insgesamt wurden 10 Gene untersucht, die Funktion von 7 dieser Gene war in S. aureus unbekannt. Zunächst sollte herausgefunden werden, ob diese 10 Zielgene: topB, polA, nusG, SA1857, SA1444, SA1063, SA0453, SA0241, SA0245, SA0367, für S. aureus essentiell sind. Es wurde versucht, jedes dieser Gene in S. aureus zu deletieren. Außer den Genen SA1444, SA0245 und nusG konnten alle Zielgene deletiert werden und waren daher für S. aureus nicht essentiell. Die Deletionsmutanten ΔtopB, ΔpolA, ΔSA1857, ΔSA1063, ΔSA0453, ΔSA0241, ΔSA0367 wurden außerdem in einem Sepsismodell in Mäusen untersucht und waren nicht attenuiert. Gene, die weder in vitro noch in vivo essentiell sind, sind nur von geringem Interesse für die Entwicklung neuer Antibiotika. Zur Untersuchung essentieller Gene in S. aureus wurden vier verschiedene konditionale Expressionssystem untersucht. Bei drei dieser Systeme wurde der wildtypische Promotor gegen einen regulierbaren Promotor ausgetauscht. Bei einem weiteren System handelte es sich um einen Antisense-RNA-Ansatz. Zur Überprüfung der konditionalen Expressionssysteme („proof-of-principle“) wurden die bekannten essentiellen Gene ligA und dnaE in S. aureus mutiert. Eines dieser konditionalen Expressionssysteme, das pLL30/Pspac/pMJ8426-System, konnte erfolgreich in S. aureus angewandt werden. Die konditionale Expression von ligA und von SA0245 wurde mit diesem System erzielt. Der Temperatur-sensitive Shuttle-Vektor pLL30 dieses konditionalen Expressionssystems enthält eine Insertionskassette, die das Antibiotikaresistenzgen cat (Chloramphenicol-Acetyltransferase) sowie den regulierbaren Promotor Pspac enthält. Ein wesentliches Merkmal des pLL30/Pspac/pMJ8426-Systems ist die stabile Integration des Resistenzmarkers cat und des Pspac-Promotors durch ein doppeltes Crossover Ereignis vor dem Zielgen. Der Temperatur-sensitive Shuttle-Vektor pLL30 kann anschließend durch mehrfaches Subkultivieren der Bakterien bei nicht permissiver Temperatur eliminiert werden. Der Repressor LacI wird auf einem Extra-Plasmid pMJ8426 kodiert und wird nach erfolgter Integration des Pspac-Promotors vor dem Zielgen in die Bakterien transformiert. Mehrere Kopien des Repressorplasmids ermöglichen eine gute Repression an Pspac. Durch die Zugabe des Induktors IPTG kann der Repressor LacI inaktiviert und die Gen-Expression induziert werden. Insbesondere konnte dieses konditionale Expressionssystem erfolgreich im Tiermodell angewandt werden. Ein weiterer Schwerpunkt dieser Arbeit bildete die genetische und funktionelle Charakterisierung von SA0367. Durch biochemische Untersuchungen wurde gezeigt, dass dieses Gen für eine FMN-enthaltende Oxidoreduktase codiert. Auf Grundlage der in dieser Arbeit gewonnenen Erkenntnisse zur Funktion des Proteins wurde das Gen SA0367, in Analogie zum orthologen Gen nfrA aus B. subtilis, in nfrA umbenannt. Die Oxidoreduktase NfrA oxidiert NADPH in Gegenwart von FMN. In Gegenwart von NADPH und FMN zeigt das Enzym NfrA außerdem Nitroreduktase- und eine leichte Disulfidreduktase-Aktivität. Induktionsexperimente im Wildtyp zeigten, dass nfrA durch oxidativen Stress, verursacht von Diamide oder Nitrofurantoin, und durch Ethanol induziert wird. Ethanol und oxidativer Stress führt zu Denaturierung von Proteinen. NfrA könnte an der Reparatur geschädigter Proteine beteiligt sein. Die Induktion von nfrA in S. aureus erfolgt unabhängig vom alternativen Sigmafaktor SigB. Durch Primer Extension-Experimente wurde eine putative PerR-Box vor dem nfrA-Gen identifiziert. Diese könnte für die Regulation von nfrA wichtig sein. Außerdem wird nfrA während des gesamten Wachstumszyklus von einem SigAabhängigen Promotor exprimiert. Die Deletionsmutante ΔnfrA zeigt nur in Gegenwart hoher Ethanolkonzentrationen von 6,5 % einen leichten Wachstumsnachteil im Vergleich zum Wildtyp. Außerdem weist die ΔnfrA-Mutante eine höhere Resistenz gegenüber Nitrofurantoin auf. In weiteren Untersuchungen wurde begonnen die Funktion der Ser/Thr-Kinase SA1063 durch Microarray-Experimente aufzuklären. Hierbei wurde deutlich, dass dieses Gen eine regulatorische Rolle bei der Zellwandsynthese in S. aureus spielen könnte.
The opportunistic human pathogen Staphylococcus aureus causes serious infectious diseases that range from superficial skin and soft tissue infections to necrotizing pneumonia and sepsis. While classically regarded as an extracellular pathogen, S. aureus is able to invade and survive within human cells. Host cell exit is associated with cell death, tissue destruction, and the spread of infection. The exact molecular mechanism employed by S. aureus to escape the host cell is still unclear. In this study, we performed a genome-wide small hairpin RNA (shRNA) screen and identified the calcium signaling pathway as being involved in intracellular infection. S. aureus induced a massive cytosolic Ca\(^{2+}\) increase in epithelial host cells after invasion and intracellular replication of the pathogen. This was paralleled by a decrease in endoplasmic reticulum Ca\(^{2+}\) concentration. Additionally, calcium ions from the extracellular space contributed to the cytosolic Ca2+ increase. As a consequence, we observed that the cytoplasmic Ca\(^{2+}\) rise led to an increase in mitochondrial Ca\(^{2+}\) concentration, the activation of calpains and caspases, and eventually to cell lysis of S. aureus-infected cells. Our study therefore suggests that intracellular S. aureus disturbs the host cell Ca\(^{2+}\) homeostasis and induces cytoplasmic Ca\(^{2+}\) overload, which results in both apoptotic and necrotic cell death in parallel or succession.
IMPORTANCE Despite being regarded as an extracellular bacterium, the pathogen Staphylococcus aureus can invade and survive within human cells. The intracellular niche is considered a hideout from the host immune system and antibiotic treatment and allows bacterial proliferation. Subsequently, the intracellular bacterium induces host cell death, which may facilitate the spread of infection and tissue destruction. So far, host cell factors exploited by intracellular S. aureus to promote cell death are only poorly characterized. We performed a genome-wide screen and found the calcium signaling pathway to play a role in S. aureus invasion and cytotoxicity. The intracellular bacterium induces a cytoplasmic and mitochondrial Ca\(^{2+}\) overload, which results in host cell death. Thus, this study first showed how an intracellular bacterium perturbs the host cell Ca\(^{2+}\) homeostasis."
Staphylococcus aureus is a major human pathogen, which can invade and survive in non-professional and professional phagocytes. Uptake by host cells is thought to contribute to pathogenicity and persistence of the bacterium. Upon internalization by epithelial cells, cytotoxic S. aureus strains can escape from the phagosome, replicate in the cytosol and induce host cell death. Here, we identified a staphylococcal cysteine protease to induce cell death after translocation of intracellular S. aureus into the host cell cytoplasm. We demonstrated that loss of staphopain A function leads to delayed onset of host cell death and prolonged intracellular replication of S. aureus in epithelial cells. Overexpression of staphopain A in a non-cytotoxic strain facilitated intracellular killing of the host cell even in the absence of detectable intracellular replication. Moreover, staphopain A contributed to efficient colonization of the lung in a mouse pneumonia model. In phagocytic cells, where intracellular S. aureus is exclusively localized in the phagosome, staphopain A did not contribute to cytotoxicity. Our study suggests that staphopain A is utilized by S. aureus to exit the epithelial host cell and thus contributes to tissue destruction and dissemination of infection.
Author summary Staphylococcus aureus is an antibiotic-resistant pathogen that emerges in hospital and community settings and can cause a variety of diseases ranging from skin abscesses to lung inflammation and blood poisoning. The bacterium can asymptomatically colonize the upper respiratory tract and skin of humans and take advantage of opportune conditions, like immunodeficiency or breached barriers, to cause infection. Although S. aureus was not regarded as intracellular bacterium, it can be internalized by human cells and subsequently exit the host cells by induction of cell death, which is considered to cause tissue destruction and spread of infection. The bacterial virulence factors and underlying molecular mechanisms involved in the intracellular lifestyle of S. aureus remain largely unknown. We identified a bacterial cysteine protease to contribute to host cell death of epithelial cells mediated by intracellular S. aureus. Staphopain A induced killing of the host cell after translocation of the pathogen into the cell cytosol, while bacterial proliferation was not required. Further, the protease enhanced survival of the pathogen during lung infection. These findings reveal a novel, intracellular role for the bacterial protease staphopain A.
Staphylococcus aureus is a Gram-positive commensal bacterium, that asymptomatically colonizes human skin and mucosal surfaces. Upon opportune conditions, such as immunodeficiency or breached barriers of the host, it can cause a plethora of infections ranging from local, superficial infections to life-threatening diseases. Despite being regarded as an extracellular pathogen, S. aureus can invade and survive within non-phagocytic and phagocytic cells. Eventually, the pathogen escapes from the host cell resulting in killing of the host cell, which is associated with tissue destruction and spread of infection. However, the exact molecular mechanisms underlying S. aureus-induced host cell death remain to be elucidated.
In the present work, a genome-wide haploid genetic screen was performed to identify host cell genes crucial for S. aureus intracellular cytotoxicity. A mutant library of the haploid cell line HAP1 was infected with the pathogen and cells surviving the infection were selected. Twelve genes were identified, which were significantly enriched when compared to an infection with a non-cytotoxic S. aureus strain.
Additionally, characteristics of regulated cell death pathways and the role of Ca2+ signaling in S. aureus-infected cells were investigated. Live cell imaging of Ca2+ reporter cell lines was used to analyze single cells. S. aureus-induced host cell death exhibited morphological features of apoptosis and activation of caspases was detected. Cellular H2O2 levels were elevated during S. aureus intracellular infection. Further, intracellular S. aureus provoked cytosolic Ca2+ overload in epithelial cells. This resulted from Ca2+ release from endoplasmic reticulum and Ca2+ influx via the plasma membrane and led to mitochondrial Ca2+ overload. The final step of S. aureus-induced cell death was plasma membrane permeabilization, a typical feature of necrotic cell death.
In order to identify bacterial virulence factors implicated in S. aureus-induced host cell killing, the cytotoxicity of selected mutants was investigated. Intracellular S. aureus employs the bacterial cysteine protease staphopain A to activate an apoptosis-like cell death characterized by cell contraction and membrane bleb formation. Phagosomal escape represents a prerequisite staphopain A-induced cell death, whereas bacterial intracellular replication is dispensable. Moreover, staphopain A contributed to efficient colonization of the lung in a murine pneumonia model.
In conclusion, this work identified at least two independent cell death pathways activated by intracellular S. aureus. While initially staphopain A mediates S. aureus-induced host cell killing, cytosolic Ca2+-overload follows later and leads to the final demise of the host cell.
The pathogen Staphylococcus aureus causes a broad range of severe diseases and is feared for its ability to rapidly develop resistance to antibiotic substances. The increasing number of highly resistant S. aureus infections has accelerated the search for alternative treatment options to close the widening gap in anti-S. aureus therapy. This study analyses the humoral immune response to vaccination of Balb/c mice with sublethal doses of live S. aureus. The elicited antibody pattern in the sera of intravenously and intramuscularly vaccinated mice was determined using of a recently developed protein array. We observed a specific antibody response against a broad set of S. aureus antigens which was stronger following i.v. than i.m. vaccination. Intravenous but not intramuscular vaccination protected mice against an intramuscular challenge infection with a high bacterial dose. Vaccine protection was correlated with the strength of the anti-S. aureus antibody response. This study identified novel vaccine candidates by using protein microarrays as an effective tool and showed that successful vaccination against S. aureus relies on the optimal route of administration.
Staphylococcus aureus ist ein grampositives Bakterium, welches häufig als kommensaler Besiedler auf der Nasen- und Rachenschleimhaut von Säugetieren vorkommt. Darüber hinaus besitzt dieser fakultativ pathogene Mikroorganismus die Fähigkeit schwer zu behandelnde Krankenhausinfektionen auszulösen. Aufgrund der weiten Verbreitung von Antibiotikaresistenzen und dem Mangel an effektiven Therapien, verursachen S. aureus Infektionen jährlich enorme Kosten für das Gesundheitssystem. S. aureus wird meist von der Nase zum primären Infektionsort übertragen, wodurch zunächst sehr häufig Wund- und Weichteilinfektionen hervor gerufen werden. Von diesem primären Infektionsort ausgehend, kann der Erreger tiefer liegende Gewebsschichten infizieren oder sich über den Blutstrom im gesamten Organismus ausbreiten. Das Spektrum an Krankheitsbildern reicht von leichten Abszessen der Haut bis zu schweren, lebensbedrohlichen Erkrankungen wie Pneumonien und akuter Sepsis.
Für die erfolgreiche Kolonisierung und Infektion des Wirtes exprimiert S. aureus eine Vielzahl unterschiedlicher Virulenzfaktoren. Die wohl größte Gruppe an Virulenzfaktoren umfasst die Proteine, die an der Immunevasion und der Umgehung von verschiedenen Abwehrstrategien des Immunsystems beteiligt sind. Das bisherige Wissen über die Interaktion von S. aureus mit dem Immunsystem des Wirtes und die zugrunde liegenden Pathogenitätsmechanismen ist bisher limitiert.
Um neue Erkenntnisse über die Interaktion von Wirt und Pathogen zu erlangen, wurden im Rahmen dieser Arbeit bislang unbekannte sekretierte und Oberflächen-assoziierte Proteine von S. aureus funktionell charakterisiert. Die Funktion der ausgewählten Proteine wurde in vitro hinsichtlich Einfluss auf Komponenten des Immunsystems, Adhäsion an Wirtsfaktoren und Invasion in eukaryotische Zellen untersucht.
Mit Hilfe der vorangegangenen in-vitro-Charakterisierung der putativen Virulenzfaktoren, konnte für die cytoplasmatische Adenylosuccinat-Synthase PurA eine neuartige Funktion identifiziert werden. PurA ist bekannt als essentielles Enzym der de novo Purin-Synthese. In dieser Arbeit wurde nun gezeigt, dass PurA zudem an der Immunevasion beteiligt ist. Durch die Bindung des humanen Faktor H des Komplementsystems schützt PurA S. aureus vor der lytischen Aktivität des Komplementsystems und verhindert die Opsonisierung des Pathogens. Basierend auf diesen Ergebnissen wurde PurA detailliert charakterisiert. In Bindungsstudien mit rekombinantem Faktor H und PurA wurde eine direkte Interaktion beider Proteine nachgewiesen, wobei Faktor H mit dem N-terminalen Bereich von PurA interagiert. Weiterhin konnte PurA durch Immunfluoreszenz und FACS-Analysen auf der Zelloberfläche nachgewiesen werden, wo es wahrscheinlich mit der Zellwand assoziiert vorliegt. Dort rekrutiert es Faktor H an die bakterielle Oberfläche und verhindert das Fortschreiten der Komplement-Kaskade und damit die Lyse des Pathogens. Aufgrund der Multifunktionalität zählt PurA somit zur Gruppe der Moonlighting Proteine.
Des Weiteren wurde die Rolle von PurA im Infektionsgeschehen in zwei unabhängigen Tiermodellen untersucht. In beiden Modellen wurde ein signifikant reduziertes Virulenzpotential der ΔpurA-Mutante beobachtet. Zukünftig soll geklärt werden, ob die verminderte Virulenz in der fehlenden Komplementevasion oder im Defekt in der Purin-Synthese begründet ist. Aufgrund der sehr starken Attenuation in allen untersuchten Infektionsmodellen sollte PurA als potentielles Target für eine Therapie von S. aureus Infektionen weiter charakterisiert werden. Im Ergebnis dieser Arbeit wurde demnach mit PurA ein neues Moonlighting Protein identifiziert, das als Inhibitor des Komplementsystems wesentlich zur Immunevasion von S. aureus beiträgt.
Für das bessere Verständnis der humoralen S. aureus-spezifischen Immunantwort, Unterschieden in der Antikörperantwort und der gebildeten Antikörperspezifitäten wurde weiterhin das während der Kolonisierung und Infektion gebildete S. aureus-spezifische Antikörperprofil untersucht. Dazu wurden Plasmen von humanen nasalen Trägern und Nicht-Trägern sowie murine Seren von infizierten Tieren untersucht. Insbesondere wurde das Pathogen-spezifische Antikörperprofil in unterschiedlichen Infektionsmodellen mit Hilfe eines Proteinarrays analysiert, der im Rahmen dieser Arbeit in einer Kooperation mit der Firma Alere Technologies (Jena, Deutschland) und universitären Forschergruppen der Universitäten Greifswald, Münster und Jena mitentwickelt wurde. Die Antikörperprofile von intramuskulär und intravenös infizierten Tieren resultierten in jeweils spezifischen Antikörperprofilen. Diese Ergebnisse deuten auf einen Zusammenhang zwischen der Art der Infektion und der gebildeten Antikörperspezifitäten hin. Wahrscheinlich beruht dies auf einer gewebespezifischen Genexpression als Anpassung an die individuellen Bedürfnisse im Wirtsorganismus. Das ausgebildete Antikörperprofil gibt somit einen Einblick in das Expressionsmuster von Virulenzfaktoren von S. aureus unter in vivo Bedingungen und trägt damit zum Verständnis der komplexen Interaktion von Pathogen und Wirt bei. Diese Untersuchungen ergänzen zudem die bisherigen Kenntnisse über die Anpassung der humoralen Immunantwort an eine asymptomatische Kolonisierung im Gegensatz zu einer akuten Infektion durch S. aureus. Darüber hinaus können die gewonnenen Ergebnisse für diagnostische Zwecke und zur Identifikation von neuen Zielstrukturen für eine Vakzin-Entwicklung genutzt werden.
Staphylococcus aureus reagiert auf veränderte Umweltbedingungen wie Hitze, pH und Chemikalien mit Hilfe globaler Regulatoren wie dem Sae (S. aureus exoprotein expression) Zweikomponenten-System. Subinhibitorische Konzentrationen einiger Antibiotika können die Expression von Virulenzfaktoren erhöhen. In dieser Arbeit wurde die Stressantwort von S. aureus auf subletale Konzentrationen des geläufigen Desinfektionsmittels Perform® untersucht. Dazu wurden biochemische Methoden wie SDS-PAGE und Massen-Spektrometrie sowie molekularbiologische Methoden wie qRT-PCR und Promotoraktivitäts-Assays eingesetzt. Davon abhängige, funktionelle Veränderungen wurden in durchfluss-zytometrischen Invasions-Assays analysiert. Perform wirkt durch die Bildung von reaktiven Sauerstoff-Spezies (ROS). Das Wachstum von S. aureus in Medien mit subletalen Konzentrationen von Perform verringerte in den Stämmen 6850, COL und ISP479C die Expression mehrerer Proteine, wohingegen im Stamm Newman eine gesteigerte Expression mehrerer Proteine festgestellt werden konnte. In der Literatur werden diese vermehrt exprimierten Proteine als sae-abhängig beschrieben. Der Effekt von Perform konnte durch das im Desinfektionsmittel enthaltene Detergenz SDS nachgeahmt werden, jedoch nicht durch Paraquat oder weitere Detergenzien wie Triton X-100 oder Tween 20. Eine Solubilisierungsreaktion durch die Detergenz-Wirkung konnte ausgeschlossen werden, da der beobachtete Effekt von lebenden Bakterien abhängt. Für Eap (extracellular adherence protein) konnte die deutlichste Steigerung der Proteinexpression festgestellt werden und eine Transkriptionsanalyse bestätigte die gesteigerte Eap-Expression. Die Promotoraktivität des sae Promotors P1 wurde sowohl durch Perform als auch durch SDS verstärkt. Die Anwesenheit von Perform und SDS hatte auch funktionelle Änderungen zur Folge: In durchflusszytometrischen Experimenten erhöhte sich beispielsweise die Invasivität auf das 2,5- bzw. 3,2-fache und die beobachteten Unterschiede konnten durch Lysostaphin Protektions Versuche bestätigt werden. Weiterhin konnte gezeigt werden, dass die gesteigerte Invasivität in Stamm Newman von Eap und dem sae-System abhängig war, während agr, sarA, sigB und FnBPs keinen entscheidenden Einfluss auf die Invasivität hatten. In dieser Arbeit wurde außerdem aufgedeckt, dass die Besonderheit des Stammes Newman durch eine Mutation in saeS (Sensor-Histidinkinase) bedingt war. Obwohl postuliert wird, dass diese Punktmutation ein konstitutiv aktiviertes sae System zur Folge hat, konnte die hohe sae Aktivität durch Perform und SDS jedoch noch weiter gesteigert werden. Durch den Austausch des gesamten sae-Operons konnte gezeigt werden, dass sich der Stamm Newman saeISP479C wie der Stamm ISP479C, und der Stamm ISP479C saeNewman sich analog zu Stamm Newman verhielt. Zusammenfassend kann aus den vorliegenden Ergebnissen geschlussfolgert werden, dass ein Aminosäurenaustausch in der Sensor-Histidinkinase SaeS des Stammes Newman verantwortlich für die gesteigerte Expression von Eap und die daraus resultierende gesteigerte Invasivität nach der Inkubation mit subletalen Konzentrationen von Perform und SDS ist. Diese Daten können dazu beitragen, die Virulenzmechanismen im Stamm Newman, speziell die Rolle des Sae-Systems, aber auch die der generellen Regulation, besser verstehen zu können.
Whereas most currently used antibiotics act by interfering with essential bacterial processes, a smaller group of antibacterials disturbs the integrity of the cell membrane. Since fatty acids are a vital component of membrane phospholipids, the type-II fatty acid biosynthesis pathway (FAS-II) of bacteria constitutes a promising drug target. The front-line anti-tuberculosis prodrug isoniazid blocks the FAS-II pathway in M. tuberculosis thereby leading to morphological changes and finally to cell lysis. When it became evident that the enoyl-ACP reductase in the FAS-II pathway is the target of the activated isoniazid, several programs were initiated to develop novel inhibitors directed against this protein in different pathogens. The S. aureus enoyl-ACP reductase (saFabI) is of particular interest since three promising drug candidates inhibiting this homologue have reached clinical trials. However, despite these prospects, no crystal structures of saFabI were publicly available at the time the present work was initiated. Thus, one major goal of this thesis was the generation of high-resolution atomic models by means of X-ray crystallography. The development of a highly reproducible approach to co-crystallize saFabI in complex with NADP+ and diphenyl ether-based inhibitors led to crystal structures of 17 different ternary complexes. Additional crystallographic experiments permitted the view into two apo-structures and two atomic models of saFabI in complex with NADPH and 2-pyridone inhibitors. Based on the established saFabI structure, molecular dynamics (MD) simulations were performed to improve our understanding of the conformational mobility of this protein. Taken together, these investigations of the saFabI structure and its flexibility served as an ideal platform to address important questions surrounding substrate and inhibitor recognition by this enzyme. Intriguingly, our saFabI structures provide several vastly different snapshots along the reaction coordinate of ligand binding and hydride transfer, including the closure of the flexible substrate binding loop (SBL). The extraordinary mobility of saFabI was confirmed by MD simulations suggesting that conformational motions indeed play a pivotal role during substrate delivery and turnover. A water chain linking the active site with a water-basin inside the homo-tetrameric enzyme was found likely to be crucial for the closure and opening of the SBL and, thus, for the catalyzed reaction. Notably, the induced-fit ligand binding process involves a dimer-tetramer transition, which could be related to the observed positive cooperativity of cofactor and substrate binding. Overall, saFabI displays several unique characteristics compared to FabI proteins from other organisms that might be necessary for the synthesis of branched-chain fatty acids, which in turn are required for S. aureus fitness in vivo. This finding may explain why S. aureus is sensitive to FAS-II inhibitors even in the presence of exogenous fatty acids. Accordingly, saFabI remains a valid drug target and our structures can be used as a molecular basis for rational drug design efforts. In fact, binding affinity trends of diphenyl ether inhibitors and, more importantly, the correlated residence times could be rationalized at the molecular level. Furthermore, the structure of saFabI in complex with the 2-pyridone inhibitor CG400549 revealed unique interactions in the wider binding crevice of saFabI compared to other FabI homologues explaining the narrow activity spectrum of this clinical candidate with proven human efficacy. In summary, these studies provide an ideal platform for the development of new, effective saFabI inhibitors as exemplified by the promising 4-pyridone PT166. In the context of this dissertation, crystal structures of the condensing enzyme KasA in complex with several analogs of the naturally occurring inhibitor thiolactomycin have been solved.
Hintergrund: Zunehmend wird der Eigenschaft von Staphylococcus aureus als fakultativ intrazellulärem Erreger Bedeutung zugemessen. Ein direkter Nachweis der in vivo Relevanz von fakultativ intrazellulärem S. aureus bleibt allerdings bisher aus. Der Mechanismus zellulärer Invasivität ist bekannt und korreliert mit verschiedenen molekularen Markern (spa-Typ, SCCmec-Typ und pls/Pls). In dieser Studie wurde die Zuverlässigkeit und Ausweitbarkeit dieser Marker getestet. Des Weiteren wurde überprüft, ob sich die zelluläre Invasivität von kolonisierenden und Infektions-assoziierten MRSA-Isolaten unterscheidet und, ob die alleinige Bestimmung molekularer Marker in vitro die Virulenz eines Isolats in vivo abzuschätzen vermag. Methoden:Insgesamt wurden 109 MRSA-Isolate gesammelt, molekular charakterisiert (spa-Typ, BURP-Analyse, SCCmec-Typ, pls, agr-Typ, Hämolyseverhalten) und das Potential zellulärer Invasivität in vitro ermittelt. Die Assoziation eines Isolates mit einer Infektion in vivo wurde nachverfolgt (93 Kolonisierer versus 16 Infektions-assoziierte-Isolate). Zusätzlich wurde eine Referenzgruppe aus 13 S. aureus-Isolaten etabliert, die klinisch mit vergleichsweise invasiven Infektionen assoziiert waren (12 Osteomyelitis-Isolate und 1 Endokarditis-Isolat). Ergebnisse: Die bekannten molekularen Marker zellulärer Invasivität korrelieren zuverlässig in einer Population klinischer MRSA-Isolate und lassen sich auch auf bisher nicht bekannte (spa- und SCCmec-) Typen ausweiten. Das Hämolyseverhalten korrelierte nicht mit der zellulären Invasivität. Der agr-Typ wurde als weiterer molekularer Marker identifiziert. Die zelluläre Invasivität war unabhängig von der Etablierung einer Infektion in vivo (mediane Invasivität der Kolonisierer 100% versus 108% der Infektions-assoziierten Studienisolate und 110% der externen Referenzisolate). Des Weiteren waren die molekularen Marker spa- und agr-Typ nicht in der Lage, die Virulenz eines MRSA-Isolats in vivo abzuschätzen. Diskussion: Die zelluläre Invasivität klinischer MRSA-Isolate korreliert zuverlässig mit molekularen Markern. Allerdings vermögen weder die zelluläre Invasivität, noch mit ihr assoziierte molekulare Marker die Etablierung einer Infektion in vivo vorherzusagen. Beide scheinen also als Surrogat-Parameter zur Abschätzung der klinischen Virulenz eines Isolats ungeeignet. Zur Klärung der Frage, ob molekulare Marker zellulärer Invasivität in anderen Abschnitten der Pathogenese von S. aureus- Infektionen eine Rolle spielen, bedarf es weiterer Studien.
The present work illustrates the structural and biochemical characterization of two diverse proteins, BadI and MenD from Rhodopseudomonas palustris and Staphylococcus aureus, respectively.
BadI or 2-ketocyclohexanecarboxyl-CoA is one of the key enzymes involved in the anaerobic degradation of aromatic compounds. The degradation of aromatic compounds is a vital process for the maintenance of the biogeochemical carbon cycle and bioremediation of xenobiotic compounds, which if present at higher concentrations can cause potential hazards to humans. Due to the relatively inert nature of aromatic compounds, enzymes catalyzing their degradation are of special interest for industrial applications. BadI is one of the key enzymes involved in the anaerobic degradation of aromatic compounds into an aliphatic moiety.
The major focus of this study was to provide mechanistic insights into the reaction catalyzed by BadI. BadI belongs to the crotonase superfamily and shares high sequence homology with the family members of MenB or dihydroxynaphthoate synthase. BadI is known to catalyze the cleavage of the cyclic ring of 2-ketocyclohexane carboxyl-CoA by hydrolyzing the C-C bond leading to the formation of the aliphatic compound pimelyl CoA. On the other hand MenB catalyzes the condensation reaction of o-succinylbenzoyl-CoA to dihydroxylnaphthoyl-CoA. A comprehensive amino acid sequence analysis between BadI and MenB showed that the active site residues of MenB from Mycobacterium tuberculosis (mtMenB) are conserved in BadI from Rhodopseudomonas palustris. MenB is involved in the menaquinone biosynthesis pathway and is a potential drug target against Mycobacterium tuberculosis as it has no known human homologs. Due to the high homology between MenB and BadI and the inability to obtain MenB-inhibitor complex structures we extended our interest to BadI to explore a potential substitute model for mtMenB as a drug target.
In addition, BadI possesses some unique mechanistic characteristics. As mentioned before, it hydrolyzes the substrate via a retro Dieckmann’s reaction contrasting its closest homolog MenB that catalyzes a ring closing reaction through a Dieckmann’s reaction. Nevertheless the active site residues in both enzymes seem to be highly conserved. We therefore decided to pursue the structural characterization of BadI to shed light on the similarities and differences between BadI and MenB and thereby provide some insights how they accomplish the contrasting reactions described above.
We determined the first structures of BadI, in its apo and a substrate mimic bound form. The crystal structures revealed that the overall fold of BadI is similar to other crotonase superfamily members. However, there is no indication of domain swapping in BadI as observed for MenB. The absence of domain swapping is quite remarkable because the domain swapped C-terminal helical domain in MenB provides a tyrosine that is imperative for catalysis and is also conserved in the BadI sequence. Comparison of the active sites revealed that the C-terminus of BadI folds onto its core in such a way that the conserved tyrosine is located in the same position as in MenB and can form interactions with the ligand molecule. The structure of BadI also confirms the role of a serine and an aspartate in ligand interaction, thus validating that the conserved active site triad participates in the enzymatic reaction. The structures also reveal a noteworthy movement of the active site aspartate that adopts two major conformations. Structural studies further illuminated close proximity of the active site serine to a water and chlorine molecule and to the carbon atom at which the carbonyl group of the true substrate would reside. Biochemical characterization of BadI using enzyme kinetics validated that the suggested active site residues are involved in substrate interaction. However, the role of these residues is very distinct, with the serine assuming a major role. Thus, the present work ascertain the participation of putative active site residues and demonstrates that the active site residues of BadI adopt very distinctive roles compared to their closest homolog MenB.
The MenD protein also referred to as SEPHCHC (2-succinyl-5-enolpyruvyl-6- hydroxy-3-cyclohexene-1-carboxylic acid) synthase is one of the enzymes involved in menaquinone biosynthesis in Staphylococcous aureus. Though S. aureus is usually considered as a commensal it can act as a remarkable pathogen when it crosses the epithelium, causing a wide spectrum of disorders ranging from skin infection to life threatening diseases. Small colony variants (SCVs), a slow growing, small sized subpopulation of the bacteria has been associated with persistent, recurrent and antibiotic resistant infections. These variants show autotrophy for thiamine, menaquinone or hemin. Menaquinone is an essential component in the electron transport pathway in gram-positive organisms. Therefore, enzymes partaking in this pathway are attractive drug targets against pathogens such as Mycobacterium tuberculosis and Bacillus subtilis. MenD, an enzyme catalyzing the first irreversible step in the menaquinone biosynthetic pathway has been implicated in the SCV phenotype of S. aureus. In the present work we explored biochemical and structural properties of this important enzyme.
Our structural analysis revealed that despite its low sequence identity of 28%, the overall fold of staphylococcal MenD (saMenD) is similar to Escherichia coli MenD (ecMenD) albeit with some significant disparities. Major structural differences can be observed near the active site region of the protein and are profound in the C-terminal helix and a loop near the active site. The loop contains critical residues for cofactor binding and is well ordered only in the ecMenD-ThDP structure, while in the apo and substrate bound structures of ecMenD the loop is primarily disordered. In our saMenD structure the loop is for the first time completely ordered in the apo form and displays a novel conformation of the cofactor-binding loop. The loop adopts an unusual open conformation and the conserved residues, which are responsible for cofactor binding are located too far away to form a productive complex with the cofactor in this conformation. Additionally, biochemical studies in conjugation with the structural data aided in the identification of the substrate-binding pocket and delineated residues contributing to its binding and catalysis. Thus the present work successfully divulged the unique biochemical and structural characteristics of saMenD.
Structural and functional elucidation of the Type VIIb secretion system from Staphylococcus aureus
(2020)
The Type VII secretion system (T7SS) is linked to virulence and long-term pathogenesis in a broad range of Gram-positive bacteria, including the human commensal and pathogen Staphylococcus aureus. The Type VIIb secretion system (T7SSb) is responsible for the export of small toxic proteins, which induce antibacterial immune responses and mediate bacterial persistence in the host. In addition, it is also involved in bacterial competition. The T7SSb requires several proteins to build up the secretion machinery. This work focuses on the structural and functional investigation of the motor ATPase EssC and the putative pore forming, multi-pass membrane component EsaA. Both proteins are indispensable for substrate secretion.
EssC belongs to the FtsK/SpoIIIE ATPase family and is conserved among the T7SSs. It contains three C-terminal, cytosolic ATPase domains, designated as EssC- D1, -D2 and -D3, whereby EssC-D3 is the most distal one. In this thesis, I am presenting the crystal structure of the EssC-D3 at 1.7 Å resolution. As the deletion of EssC-D3 abrogates substrate export, I have demonstrated that this domain comprises a hydrophobic, surface-exposed pocket, which is required for substrate secretion. More specifically, I have identified two amino acids involved in the secretion process. In addition, my results indicate that not only EssC-D3 is important for substrate interaction but also EssC-D2 and/or EssC-D1. Unlike in the related Yuk T7SSb of Bacillus subtilis, the ATPase activity of D3 domain contributes to substrate secretion. Mutation of the modified Walker B motif in EssC-D3 diminishes substrate secretion completely.
The membrane protein EsaA encompasses an extracellular segment spanning through the cell wall of S. aureus. I was able to reveal that this part folds into a stable domain, which was crystallized and diffracted up to 4 Å. The first attempts to dissolve the structure failed due to a lack of homologues structures. Therefore, crystals for single-wavelength anomalous dispersion, containing selenomethionyl-substitutes, were produced and the structure solution is still in progress. Preliminary experiments addressing the function of the extracellular domain indicate an important role in substrate secretion and bacterial competition.
Bacterial functional membrane microdomains (FMMs) are membrane platforms that resemble lipid rafts of eukaryotic cells in certain functional and structural aspects. Lipid rafts are nanometer-sized, dynamic clusters of proteins and lipids in eukaryotic cell membranes that serve as signaling hubs and assembling platforms. Yet, studying these structures can often be hampered by the complexity of a eukaryotic cell. Thus, the analogous structures of prokaryotes are an attractive model to study molecular traits of this type of membrane organization.
Similar to eukaryotic lipid rafts, the bacterial FMMs are comprised of polyisoprenoid lipids, scaffold proteins and a distinct set of membrane proteins, involved in signaling or secretion. Investigating bacterial FMMs not only contributes to the understanding of the physiological importance of FMMs in bacteria, but also helps to elucidate general principles of rafts beyond prokaryotes.
In this work, a bacterial model organism was used to investigate effects of synthetic overproduction of the raft scaffolding proteins on bacterial physiology. This overexpression causes an unusual stabilization of the FMM-harbored protease FtsH and therefore the proteolytic targets of FtsH are not correctly regulated. Developmental defects and aberrances in shape are the consequence, which in turn negatively affects cell physiology. These findings may be adapted to better understand lipid raft processes in humans, where flotillin upregulation is detected along with development of neurological diseases.
Moreover, it was aimed at understanding the FMM-proteome of the human pathogen Staphylococcus aureus. An in-depth quantitative mass-spectrometry analysis reveals adaption of the protein cargo during different conditions, while maintaining a distinct set of core FMM proteins. As a case study, the assembly of the type VII secretion system was shown to be dependent on FMM integrity and more specifically on the activity of the FMM-scaffold flotillin. This secretion system is important for the virulence of this pathogen and its secretion efficiency can be targeted by small molecules that inhibit flotillin activity. This opens new venues for non-conventional antimicrobial compounds to treat staphylococcal infections.
Scaffold proteins are ubiquitous chaperones that promote efficient interactions between partners of multi-enzymatic protein complexes; although they are well studied in eukaryotes, their role in prokaryotic systems is poorly understood. Bacterial membranes have functional membrane microdomains (FMM), a structure homologous to eukaryotic lipid rafts. Similar to their eukaryotic counterparts, bacterial FMM harbor a scaffold protein termed flotillin that is thought to promote interactions between proteins spatially confined to the FMM. Here we used biochemical approaches to define the scaffold activity of the flotillin homolog FloA of the human pathogen Staphylococcus aureus, using assembly of interacting protein partners of the type VII secretion system (T7SS) as a case study. Staphylococcus aureus cells that lacked FloA showed reduced T7SS function, and thus reduced secretion of T7SS-related effectors, probably due to the supporting scaffold activity of flotillin. We found that the presence of flotillin mediates intermolecular interactions of T7SS proteins. We tested several small molecules that interfere with flotillin scaffold activity, which perturbed T7SS activity in vitro and in vivo. Our results suggest that flotillin assists in the assembly of S. aureus membrane components that participate in infection and influences the infective potential of this pathogen.
Staphylococcus aureus ist ein bedeutender opportunistischer Krankheitserreger, der eine Vielzahl von Infektionen in Menschen und Tieren hervorrufen kann. Das Krankheitsbild reicht von leichten Hautinfektionen bis hin zu lebensbedrohlichen Infektionen wie Endokarditis, Sepsis oder Pneumonien. S. aureus ist ein Haupterreger nosokomialer Infektionen. Besonders die Antibiotikaresistenzentwicklung von S. aureus–Stämmen ist problematisch. Als wirksame Antibiotika können zur Zeit oft nur noch Vancomycin, Synercid oder Linezolid zur Therapie eingesetzt werden. Die alarmierende Resistenzentwicklung in S. aureus verdeutlicht, dass die Entwicklung neuer Antibiotika und die Identifizierung neuer bakterieller Angriffsstrukturen dringend erforderlich ist. Gängige antiinfektive Therapeutika sind gegen die bakterielle Zellwandsynthese, den DNA- und RNA-Stoffwechsel oder die Proteinbiosynthese gerichtet. In dieser Arbeit sollten Virulenz-relevante Zielstrukturen für die Entwicklung neuer Antibiotika untersucht werden. Insgesamt wurden sieben Gene analysiert, von denen vier zu Anfang dieser Arbeit in S. aureus noch nicht charakterisiert waren. Die Zielgene (clpP, purH, ssrA und smpB) in S. aureus sollten deletiert werden, um ihre Überlebensnotwendigkeit in vitro- und in vivo zu überprüfen. Eine Deletion gelang bei den Genen clpP und purH, die somit als nicht essenziell in S. aureus zu betrachten sind. Die bereits zuvor als nicht-essenziell charakterisierten Gene arlR, arlS und putP wurden deletiert und die Mutanten dclpP, darlR, darlS, dpurH und dputP wurden phänotypisch in Hinsicht auf ihren Einfluss auf die Pathogenität in S. aureus analysiert. Die differenzielle Genexpression der Mutanten dclpP und darlR wurde mit Hilfe von Microarray-Hybridisierungsexperimenten untersucht. Die ∆clpP-Mutante zeigte einen starken Wachstumsdefekt bei verschiedenen Temperaturen (30, 37, 42°C) und war nicht mehr in der Lage bei 20°C zu wachsen. Ebenso war das Wachstum unter anaeroben Bedingungen stark beeinträchtigt. Der Stamm dclpP wies eine verringerte hämolytische Aktivität sowie eine verminderte Adhärenz an Polystyren auf. Außerdem konnte eine stark erhöhte autolytische Aktivität in einem Triton X-100-Assay beobachtet werden. In einem Invasions-Zellkulturassay mit 293T-Epithelzellen konnte eine ~10-fach erhöhte Invasivität im Vergleich zu dem isogenen Wildtyp festgestellt werden. Die Komplementierung der ∆clpP-Mutante durch Einführung eines clpP-Expressionsvektors führte nahezu bei allen getesteten Bedingungen zur Wiederherstellung des wildtypischen Phänotyps. Die Transkriptomanalyse der dclpP-Mutante ergab eine deutliche Veränderung in der Genexpression (15 % aller Gene). Eine computerunterstützte Analyse der Upstreambereiche der deregulierten Gene führte zu der Identifizierung verschiedener Regulons, die bei der bakteriellen Antwort auf verschiedene Stressbedingungen eine Rolle spielen. Die clpP-Deletion betrifft besonders Regulatoren, deren Aktivität in Abhängigkeit zu veränderten Redox-Bedingungen reguliert wird, wie z. B. verschiedenen Stressbedingungen und Anaerobiose. Die Konstruktion der darlR- und darlS-Mutanten führte zu einer gesteigerten hämolytischen Aktivität, einer erhöhten Adhärenz an Polystyren sowie einer erhöhten autolytischen Aktivität in Triton X-100-Assays. Die Internalisierungsrate durch 293T-Epithelzellen war vermindert. Die darlR-Mutante wurde in einem Katheter-assoziierten Infektionsmodell in Ratten eingesetzt. Die kompetitive Infektion mit Mutante und Wildtyp ergab einen deutlichen Nachteil bei der Etablierung einer Infektion durch die Mutante. Die Transkriptomanalyse der 8325darlR-Mutante in der exponenziellen und in der stationären Phase unterstreicht den großen Einfluss des ArlRS-Zwei-Komponenten-Systems auf die Regulation der Genexpression in S. aureus. In der exponenziellen Phase wurden insgesamt 5 % und in der stationären Phase 15 % der Gene differenziell exprimiert. dpurH- und dputP-Mutanten wiesen in vitro keine Veränderungen im Wachstums-verhalten, der Biofilmbildung oder hämolytischen Aktivität auf. In einem Infektionsmodell in Ratten führte die Deletion von purH in dem S. aureus-Stamm MA12 zu einer signifikanten Verminderung der Virulenz. Die Herstellung von smpB- und ssrA-Deletionsmutanten verlief ohne Erfolg. Es wurde versucht, einen direkten Nachweis für den essenziellen Charakter dieser Gene durch den Einsatz konditional letaler Expressionssysteme zu erbringen. Weder der Austausch des wildtypischen durch einen regulierbaren Promotor noch eine Antisense-RNA-Strategie war für eine eindeutige Klärung dieser Frage ausreichend. Es konnte durch diese Arbeit jedoch gezeigt werden, dass die Antisense-RNA-Strategie eine Beeinträchtigung des Wachstums von S. aureus bewirkt.
Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) of clonal complex CC398 typically carry various antimicrobial resistance genes, many of them located on plasmids. In the bovine LA-MRSA isolate Rd11, we previously identified plasmid pAFS11 in which resistance genes are co-localized with a novel ica-like gene cluster, harboring genes required for polysaccharide intercellular adhesin (PIA)-mediated biofilm formation. The ica genes on pAFS11 were acquired in addition to a pre-existing ica locus on the S. aureus Rd11 chromosomal DNA. Both loci consist of an icaADBC operon and icaR, encoding a corresponding icaADBC repressor. Despite carrying two biofilm gene copies, strain Rd11 did not produce PIA and transformation of pAFS11 into another S. aureus strain even slightly diminished PIA-mediated biofilm formation. By focusing on the molecular background of the biofilm-negative phenotype of pAFS11-carrying S. aureus, we identified the pAFS11-borne ica locus copy as functionally fully active. However, transcription of both plasmid- and core genome-derived icaADBC operons were efficiently suppressed involving IcaR. Surprisingly, although being different on the amino acid sequence level, the two IcaR repressor proteins are mutually replaceable and are able to interact with the icaA promoter region of the other copy. We speculate that this regulatory crosstalk causes the biofilm-negative phenotype in S. aureus Rd11. The data shed light on an unexpected regulatory interplay between pre-existing and newly acquired DNA traits in S. aureus. This also raises interesting general questions regarding functional consequences of gene transfer events and their putative implications for the adaptation and evolution of bacterial pathogens.
The Staphylococcus aureus two component system (TCS) sae governs expression of numerous virulence factors, including Eap (extracellular adherence protein), which in turn among other functions also mediates invasion of host cells. The sae TCS is encoded by the saePQRS operon, with saeS coding for the sensor histidine kinase (SaeS) and saeR encoding the response regulator (SaeR). The saeRS system is preceded by two additional open reading frames (ORFs), saeP and saeQ, which are predicted to encode a lipoprotein (SaeP) and a membrane protein (SaeQ), respectively. Earlier, we have shown that SDS-containing subinhibitory concentrations of biocides (Perform®) and SDS alone activate sae transcription and increase cellular invasiveness in S. aureus strain Newman. The effect is associated with an amino acid exchange in the N-terminus of SaeS (L18P), specific to strain Newman.
In this work, the role of whether the two additional genes, saePQ coding for the accessory proteins SaeP and SaeQ, respectively, are involved in SDS-mediated saeRS was investigated. It could demonstrated that the lack of the SaeP protein resulted in an increased saeRS transcription without SDS stress in both SaeSL/P variants, while the SDS effect was less pronounced on sae and eap expression compared to the Newman wildtype, suggesting that the SaeP protein represses the sae system. Also, SDS-mediated inductions of sae and eap transcription along with enhanced invasion were found to be dependent on presence of the SaeSP variant in Newman wildtype. On the other hand, the study also shows that the saePQ region of the sae operon is required for fully functional two-component system saeRS under normal growth conditions, but it is not involved in SDS-mediated activation of the saeS signaling and sae-target class I gene, eap.
In the second approach, the study investigates whether SDS-induced sae expression and host cell invasion is common among S. aureus strains not carrying the (L18P) point mutation. To demonstrate this strain Newman, its isogenic saeS mutants, and various S. aureus isolates were analysed for sae, eap expression and cellular invasiveness. Among the strains tested, SDS exposure resulted only in an increase of sae transcription, Eap production and cellular invasiveness in strain Newman wild type and MRSA strain ST239-635/93R, the latter without an increase in Eap. Interestingly, the epidemic community-associated MRSA strain, USA300 LAC showed a biphasic response in sae transcription at different growth stages, which, however, was not accompanied by increased invasiveness. All other clinical isolates investigated displayed a decrease of the parameters tested. While in strain Newman the SDS effect was due to the saeSP allele, this was not the case in strain ST239-635/93R and the biphasic USA300 strains. Also, increased invasiveness of ST239-635/93R was found to be independent of Eap production. Furthermore, to investigate the global effect of SDS on sae target gene expression, strain Newman wild-type and Newman ∆sae were treated with SDS and analyzed for their transcription profiles of sae target genes using microarray assays. We could show that subinhibitory concentrations of SDS upregulate and downregulate gene expression of several signaling pathways involved in biosynthetic, metabolic pathways as well as virulence, host cell adherence, stress reponse and many hypothetical proteins.
In summary, the study sheds light on the role of the upstream region saePQ in SDS-mediated saeRS and eap expression during S. aureus SDS stress. Most importantly, the study also shows that subinhibitory SDS concentrations have pronounced strain-dependent effects on sae transcription and subsequent host cell invasion in S. aureus, with the latter likely to be mediated in some strains by other factors than the known invasin Eap and FnBP proteins. Moreover, there seems to exist more than the saeSP-mediated mechanism for SDS-induced sae transcription in clinical S. aureus isolates. These results help to further understand and clarify virulence and pathogenesis mechanisms and their regulation in S. aureus.
Staphylococcus aureus (S. aureus) is well known to express a plethora of toxins of which the pore-forming hemolysin A (α-toxin) is the best-studied cytolysin. Pore-forming toxins (PFT) permeabilize host membranes during infection thereby causing concentration-dependent effects in host cell membranes ranging from disordered ion fluxes to cytolysis. Host cells possess defense mechanisms against PFT attack, resulting in endocytosis of the breached membrane area and delivery of repair vesicles to the insulted plasma membrane as well as a concurrent release of membrane repair enzymes. Since PFTs from several pathogens have been shown to recruit membrane repair components, we here investigated whether staphylococcal α-toxin is able to induce these mechanisms in endothelial cells. We show that S. aureus α-toxin induced increase in cytosolic Ca2+ in endothelial cells, which was accompanied by p38 MAPK phosphorylation. Toxin challenge led to increased endocytosis of an extracellular fluid phase marker as well as increased externalization of LAMP1-positive membranes suggesting that peripheral lysosomes are recruited to the insulted plasma membrane. We further observed that thereby the lysosomal protein acid sphingomyelinase (ASM) was released into the cell culture medium. Thus, our results show that staphylococcal α-toxin triggers mechanisms in endothelial cells, which have been implicated in membrane repair after damage of other cell types by different toxins.